Andrea Antinori

Best Publications

• Updated research nosology for HIV-associated neurocognitive disorders

  A. Antinori;G. Arendt;J. T. Becker;B. J. Brew

  3098
  Citations

• Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study

  Alison J Rodger;Valentina Cambiano;Tina Bruun;Pietro Vernazza

  1068
  Citations

• Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naïve patients.

  A d'Arminio Monforte;A C Lepri;G Rezza;P Pezzotti

  785
  Citations

• Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection.

  Adriana Ammassari;Rita Murri;Patrizio Pezzotti;Maria Paola Trotta

  673
  Citations

• Correlates and predictors of adherence to highly active antiretroviral therapy: overview of published literature.

  Adriana Ammassari;Maria Paola Trotta;Rita Murri;Francesco Castelli

  672
  Citations

• Once-daily dolutegravir versus darunavir plus ritonavir in antiretroviral-naive adults with HIV-1 infection (FLAMINGO): 48 week results from the randomised open-label phase 3b study

  Bonaventura Clotet;Judith Feinberg;Jan Van Lunzen;Marie Aude Khuong-Josses

  630
  Citations

• Late presentation of HIV infection: a consensus definition

  A Antinori;T Coenen;D Costagiola;N Dedes

  627
  Citations

• Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study

  Linda Wittkop;Huldrych F Günthard;Frank de Wolf;David Dunn

  492
  Citations

• Coformulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection (GS-US-380–1490): a randomised, double-blind, multicentre, phase 3, non-inferiority trial

  Paul E. Sax;Anton Pozniak;M. Luisa Montes;Ellen Koenig

  433
  Citations

• Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials

  Unknown

  428
  Citations

• Persistence of neuropsychologic deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment: prevalence and risk factors.

  Valerio Tozzi;Pietro Balestra;Rita Bellagamba;Angela Corpolongo

  399
  Citations

• Depressive symptoms, neurocognitive impairment, and adherence to highly active antiretroviral therapy among HIV-infected persons.

  Adriana Ammassari;Andrea Antinori;Maria Stella Aloisi;Maria Paola Trotta

  392
  Citations

• Depression is a risk factor for suboptimal adherence to highly active antiretroviral therapy.

  Fabrizio Starace;Adriana Ammassari;Maria Paola Trotta;Rita Murri

  357
  Citations

• Diagnosis of AIDS-related focal brain lesions A decision-making analysis based on clinical and neuroradiologic characteristics combined with polymerase chain reaction assays in CSF

  Andrea Antinori;A. Ammassari;A. De Luca;A. Cingolani

  334
  Citations

• All-cause mortality in treated HIV-infected adults with CD4 ≥500/mm3 compared with the general population: evidence from a large European observational cohort collaboration

  Charlotte Lewden;Vincent Bouteloup;Stéphane De Wit

  326
  Citations

• CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: an observational cohort study

  Cristina Mussini;Patrizia Lorenzini;Alessandro Cozzi-Lepri;Giuseppe Lapadula

  325
  Citations

• Usefulness of monitoring HIV drug resistance and adherence in individuals failing highly active antiretroviral therapy: a randomized study (ARGENTA).

  Antonella Cingolani;Andrea Antinori;Maria Gabriella Rizzo;Rita Murri

  316
  Citations

• Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study

  John Gregson;Michele Tang;Nicaise Ndembi;Raph L Hamers

  287
  Citations

• Medication adherence among HIV+ adults: Effects of cognitive dysfunction and regimen complexity

  Unknown

  280
  Citations

• Better response to chemotherapy and prolonged survival in AIDS-related lymphomas responding to highly active antiretroviral therapy.

  Andrea Antinori;Antonella Cingolani;Lucia Alba;Adriana Ammassari

  273
  Citations